Nelson Dusetti, Head of the Translational Research and Innovative Therapies Department at the Cancer Research Centre of Marseille (CRCM), shared a post on LinkedIn:
“It’s been a great honor to present at the European Pancreatic Club 2025 in Düsseldorf, where I delivered two lectures:
1. State-of-the-art: Personalizing Pancreatic Cancer Treatments
2. Optimizing Treatment Selection in Pancreatic Cancer. The Contribution of Preclinical Models
Preparing these conferences has been especially meaningful, as it led me, together with Prof. Pascal Hammel and colleagues from the Club Français du Pancréas, to write a comprehensive review now published in “Cancer Treatment Reviews” were we extensively develop the concepts and data I presented during the EPC meeting.
Feel free to read our review for a deeper dive into these topics!
“Medical management of pancreatic cancer: from personalization to broadening treatment strategies”.
I warmly thank the European Pancreatic Club, the Anticancer Fund and Pancreatic Cancer Europe for the invitation and support, and for the excellent organization and inspiring discussions.”
More Posts Featuring Nelson Dusetti.